In addition, ICI treatment led to a notable augmentation in CD8 and CD56 expression in mouse tumor tissues, in comparison to the untreated control group (all P ≤ 0.001) (Supplementary Figure S1C). This evidence concerns the gene CD8A and neoplasm.